125 related articles for article (PubMed ID: 11036680)
1. Repetitive analyses of P-glycoprotein in chronic myeloid leukaemia.
De Moerloose B; Muylaert A; Gemmel F; Janssens A; Poppe B; Dhooge C; Benoit Y; Van Hove W; Philippé J
Acta Clin Belg; 2000; 55(4):215-21. PubMed ID: 11036680
[TBL] [Abstract][Full Text] [Related]
2. Detection of multidrug-resistant protein, P-glycoprotein in childhood leukaemia and lymphoma.
Mizuno Y; Hara T; Nagata M; Tawa A; Tsuruo T; Ueda K
Eur J Pediatr; 1991 Apr; 150(6):416-8. PubMed ID: 1674913
[TBL] [Abstract][Full Text] [Related]
3. 99mTc tetrofosmin scintigraphy in acute leukaemia: the relationship between marrow uptake of tetrofosmin and P-glycoprotein and chemotherapy response.
Sükan A; Yapar Z; SAhin B; Kara O; Fuat Yapar A; CEtiner S; Kibar M
Nucl Med Commun; 2004 Aug; 25(8):777-85. PubMed ID: 15266171
[TBL] [Abstract][Full Text] [Related]
4. Studies of P-glycoprotein in chronic myelogenous leukaemia patients: expression, activity and correlations with CD34 antigen.
Turkina AG; Baryshnikov AY; Sedyakhina NP; Folomeshkina SV; Sokolova MA; Choroshco ND; Stavrovskaya AA
Br J Haematol; 1996 Jan; 92(1):88-96. PubMed ID: 8562416
[TBL] [Abstract][Full Text] [Related]
5. P-glycoprotein expression in refractory hematological neoplasms and circumvention of resistance with verapamil or cyclosporine A containing protocols.
Beksaç M; Akan H; Koç H; Ilhan O; Ertürk S; Güneyli A; Ikizünal Y; Sardaş OS
Med Oncol Tumor Pharmacother; 1992; 9(2):101-5. PubMed ID: 1364132
[TBL] [Abstract][Full Text] [Related]
6. [The prognostic significance of P-glycoprotein in children with acute lymphoblastic leukemia and neuroblastoma].
De Moerloose B
Verh K Acad Geneeskd Belg; 2005; 67(1):45-54. PubMed ID: 15828306
[TBL] [Abstract][Full Text] [Related]
7. Targeting P-Glycoprotein: Nelfinavir Reverses Adriamycin Resistance in K562/ADR Cells.
Liu W; Meng Q; Sun Y; Wang C; Huo X; Liu Z; Sun P; Sun H; Ma X; Liu K
Cell Physiol Biochem; 2018; 51(4):1616-1631. PubMed ID: 30497065
[TBL] [Abstract][Full Text] [Related]
8. Expression of the multidrug transporter, P-glycoprotein, in chronic myelogenous leukaemia cells in blast crisis.
Kuwazuru Y; Yoshimura A; Hanada S; Ichikawa M; Saito T; Uozumi K; Utsunomiya A; Arima T; Akiyama S
Br J Haematol; 1990 Jan; 74(1):24-9. PubMed ID: 1968762
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
10. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance.
Kuwazuru Y; Yoshimura A; Hanada S; Utsunomiya A; Makino T; Ishibashi K; Kodama M; Iwahashi M; Arima T; Akiyama S
Cancer; 1990 Sep; 66(5):868-73. PubMed ID: 1974821
[TBL] [Abstract][Full Text] [Related]
11. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
[TBL] [Abstract][Full Text] [Related]
12. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
13. Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia.
Wuchter C; Karawajew L; Ruppert V; Schrappe M; Harbott J; Ratei R; Dörken B; Ludwig WD
Br J Haematol; 2000 Jul; 110(1):154-60. PubMed ID: 10930993
[TBL] [Abstract][Full Text] [Related]
14. Drug resistance in hematologic malignancies.
Marie JP
Curr Opin Oncol; 2001 Nov; 13(6):463-9. PubMed ID: 11673686
[TBL] [Abstract][Full Text] [Related]
15. Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia.
Pallis M; Turzanski J; Harrison G; Wheatley K; Langabeer S; Burnett AK; Russell NH
Br J Haematol; 1999 Feb; 104(2):307-12. PubMed ID: 10050713
[TBL] [Abstract][Full Text] [Related]
16. Prolongation of medium exchange is associated with a decrease in function but not expression of the P-glycoprotein pump in leukaemic cells.
Hegewisch-Becker S; Faltz C; Hossfeld DK
Eur J Haematol; 1996; 56(1-2):12-22. PubMed ID: 8599988
[TBL] [Abstract][Full Text] [Related]
17. P-glycoprotein and drug resistance in acute leukemias and in the blastic crisis of chronic myeloid leukemia.
Carulli G; Petrini M; Marini A; Vaglini F; Caracciolo F; Grassi B
Haematologica; 1990; 75(6):516-21. PubMed ID: 1982999
[TBL] [Abstract][Full Text] [Related]
18. Analysis of MDR1 and MDR3 multidrug resistance gene expression and amplification in consecutive samples in patients with acute leukaemias.
MacFarland A; Dawson AA; Pearson CK
Leuk Lymphoma; 1995 Sep; 19(1-2):135-40. PubMed ID: 8574159
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Tsimberidou AM; Paterakis G; Androutsos G; Anagnostopoulos N; Galanopoulos A; Kalmantis T; Meletis J; Rombos Y; Sagriotis A; Symeonidis A; Tiniakou M; Zoumbos N; Yataganas X
Leuk Res; 2002 Feb; 26(2):143-54. PubMed ID: 11755464
[TBL] [Abstract][Full Text] [Related]
20. Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells.
Quiney C; Billard C; Faussat AM; Salanoubat C; Kolb JP
Leuk Lymphoma; 2007 Aug; 48(8):1587-99. PubMed ID: 17701591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]